Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Aller… (NCT05177744) | Clinical Trial Compass
CompletedNot Applicable
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
Croatia1,156 participantsStarted 2022-10-05
Plain-language summary
Single-center, cross-sectional, longitudinal, observational, population based cohort study with stratified sample (by age group, gender, and residential area).
Who can participate
Age range
6 Years – 18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Proven sensitization to at least one food allergen with a diagnosis of at least one allergic disease for at least one year
* Clinical diagnosis of allergic rhinitis (AR) for at least 1 year with symptoms of the nose, induced after exposure to allergens via IgE-mediated hypersensitivity reactions (symptoms of watery rhinorrhea, nasal obstruction, nasal itching and sneezing).
* Diagnosis of atopic dermatitis (AD) with AD symptoms lasting for more than 3 months, with or without food allergy
Additional inclusion criteria:
• Significant clinical allergy to indoor and outdoor allergens, an food allergens with positive skin prick test (SPT) and specific IgE levels (\>0.35kUA/L)
Exclusion Criteria:
* Known inborn or perinatal pulmonary disease;
* Pulmonary malformation
* Oxygen therapy after birth with a duration of more than 24 h
* Ventilator support or mechanical ventilation after birth
* Diagnosis of cystic fibrosis
* Primary ciliary dyskinesia
* Heart failure diagnosed after birth affecting pulmonary circulation
* Major respiratory diseases such as e.g. interstitial lung disease and other congenital and serious chronic disease
* Fever of at least 38.5 °C during the last two weeks prior to the planned visit
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Lung function tests
Timeframe: 6 months, Asthmatic patients will be regularly controlled even more often in case of exacerbations.